This company may still be operating, however this listing is no longer active. Find out why through their latest events.
MusclePharm Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Eric Hillman
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
2.1yrs
CEO ownership
n/a
Management average tenure
2.8yrs
Board average tenure
2.4yrs
Recent management updates
Recent updates
CEO
Eric Hillman
2.1yrs
Tenure
Mr. Eric Hillman serves as Co-Chairman and Chief Executive Officer of Europa Sports Products, Inc. He is Chief Executive Officer and Director at MusclePharm Corporation since February 13, 2023. Eric Hillma...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Eric Hillman
CEO & Director
2.1yrs
no data
no data
John Mills
Senior Managing Director
no data
no data
no data
Anthony Todaro
Interim Chief Financial Officer
no data
no data
no data
Eric Chin
Chief Accounting Officer & Director
2.8yrs
no data
no data
Roscoe Moore
Chief Scientific Director & Member of Scientific Advisory Board
14.6yrs
no data
no data
2.8yrs
Average Tenure
Experienced Management: MSLP.Q's management team is considered experienced (2.8 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Eric Hillman
CEO & Director
2.1yrs
no data
no data
Eric Chin
Chief Accounting Officer & Director
2.7yrs
no data
no data
Roscoe Moore
Chief Scientific Director & Member of Scientific Advisory Board
no data
no data
no data
Nicholas Rubin
Director
2.2yrs
no data
no data
Michael Heller
Independent Director
4.2yrs
US$75.00k
no data
2.4yrs
Average Tenure
49yo
Average Age
Experienced Board: MSLP.Q's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/03/08 13:24
End of Day Share Price
2025/03/05 00:00
Earnings
2022/03/31
Annual Earnings
2021/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MusclePharm Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.